ebomi
Colour theme
Sign in
Insider · CIK 0001645333

Column Group II GP, LP

CIK 0001645333 Name as filed on the most recent filing

Filed as Column Group II GP, LP (75)

203 transaction lines · from 75 filings · filed 2016-09-22 to 2023-11-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-11-16 P, Open-market purchase NGM Biopharmaceuticals IncNGM 3,627, acquired Open Form 4 filing 0000950170-23-064847
2023-11-15 P, Open-market purchase NGM Biopharmaceuticals IncNGM 11,880, acquired Open Form 4 filing 0000950170-23-064847
2023-01-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 883,403, acquired Open Form 4 filing 0000899243-23-003130
2023-01-30 P, Open-market purchase NGM Biopharmaceuticals IncNGM 37,707, acquired Open Form 4 filing 0000899243-23-003130
2023-01-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 49,494, acquired Open Form 4 filing 0000899243-23-002630
2023-01-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2,498, acquired Open Form 4 filing 0000899243-23-002375
2023-01-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 188,105, acquired Open Form 4 filing 0000899243-23-002375
2023-01-12 P, Open-market purchase NGM Biopharmaceuticals IncNGM 26,603, acquired Open Form 4 filing 0000899243-23-001854
2023-01-11 P, Open-market purchase NGM Biopharmaceuticals IncNGM 994,840, acquired Open Form 4 filing 0000899243-23-001694
2023-01-10 P, Open-market purchase NGM Biopharmaceuticals IncNGM 484,519, acquired Open Form 4 filing 0000899243-23-001694
2022-12-12 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,493, acquired Open Form 4 filing 0000899243-22-038465
2022-11-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 21,646, acquired Open Form 4 filing 0000899243-22-036912
2022-11-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 179,942, acquired Open Form 4 filing 0000899243-22-036912
2022-11-04 P, Open-market purchase NGM Biopharmaceuticals IncNGM 165,320, acquired Open Form 4 filing 0000899243-22-035274
2022-11-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 519,107, acquired Open Form 4 filing 0000899243-22-035274
2022-10-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 373,638, acquired Open Form 4 filing 0000899243-22-034559
2022-10-26 P, Open-market purchase NGM Biopharmaceuticals IncNGM 353,041, acquired Open Form 4 filing 0000899243-22-034352
2022-10-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 242,387, acquired Open Form 4 filing 0000899243-22-034352
2022-06-09 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 13,286,174, acquired Open Form 4 filing 0000899243-22-022212
2022-06-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 445,739, acquired Open Form 4 filing 0000899243-22-021215
2022-06-01 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 1,237,400, acquired Open Form 4 filing 0000899243-22-020688
2022-05-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 832,267, acquired Open Form 4 filing 0000899243-22-020688
2022-05-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 36,453, acquired Open Form 4 filing 0000899243-22-020202
2022-05-26 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 272,582, acquired Open Form 4 filing 0000899243-22-020202
2022-05-25 P, Open-market purchase Rapt Therapeutics, Inc.RAPT 2 lines 23,664, acquired Open Form 4 filing 0000899243-22-019937
2022-05-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 581,624, acquired Open Form 4 filing 0000899243-22-019689
2022-05-24 P, Open-market purchase Rapt Therapeutics, Inc.RAPT 2 lines 195,802, acquired Open Form 4 filing 0000899243-22-019470
2022-05-24 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 238,325, acquired Open Form 4 filing 0000899243-22-019689
2022-05-23 P, Open-market purchase Rapt Therapeutics, Inc.RAPT 2 lines 127,943, acquired Open Form 4 filing 0000899243-22-019470
2022-05-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 256,533, acquired Open Form 4 filing 0000899243-22-019208
2022-05-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 273,922, acquired Open Form 4 filing 0000899243-22-019208
2022-05-18 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 827,224, acquired Open Form 4 filing 0000899243-22-018848
2022-05-17 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 1,194,779, acquired Open Form 4 filing 0000899243-22-018848
2022-05-16 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 427,891, acquired Open Form 4 filing 0000899243-22-018399

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Column Group II GP, LP, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001645333

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.